NCT00326495 2017-07-24BAY 43-9006 Plus Cetuximab to Treat Colorectal CancerNational Institutes of Health Clinical Center (CC)Phase 2 Completed51 enrolled 11 charts
NCT00865709 2014-12-11Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) SubjectsBayerPhase 2 Completed198 enrolled 18 charts